wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35896106-455AD047-8017-4F66-B492-F713F4D28FB3
Q35896106-455AD047-8017-4F66-B492-F713F4D28FB3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35896106-455AD047-8017-4F66-B492-F713F4D28FB3
Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study.
P2860
Q35896106-455AD047-8017-4F66-B492-F713F4D28FB3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35896106-455AD047-8017-4F66-B492-F713F4D28FB3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
410941928f45cf8851cb63640f921e7670722a0f
P2860
Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.